Litmys Managing Partner Harris Kaplan will attend Advanced Therapies USA 2026, taking place November 4–5, 2026, at the Hynes Convention Center in Boston.

The conference brings together leaders from biotechnology, pharmaceutical companies, research institutions, and the broader advanced therapies ecosystem to explore the latest developments in cell therapy, gene therapy, gene editing, and regenerative medicine. Discussions will span the development and commercialization process, including clinical innovation, manufacturing, regulatory considerations, pricing, reimbursement, and market access.

While advanced therapies offer the potential to transform patient outcomes, their path to commercial success presents unique challenges. Complex treatment pathways, specialized delivery requirements, high costs, and payer considerations can all influence whether promising innovations achieve meaningful adoption.

Drawing on more than four decades of life sciences commercialization experience, Harris looks forward to connecting with industry leaders to discuss how understanding adoption barriers earlier in development can help companies strengthen their clinical and commercial strategies, build more realistic market forecasts, and prepare for successful market entry.

To connect with Harris during the conference, please reach out.